The first drug therapy approved for diabetic macular edema (DME) and diabetic retinopathy (DR) in patients with DME 1

DME

DR in patients with DME

Dosing and Safety

Resources
Resources for your patients.
LUCENTIS Direct
Simple, personalized ordering.
LUCENTIS Co-pay Card Program
Support for your patients with commercial insurance.
LUCENTIS Access Solutions
Access and reimbursement services for your patients.